PCOS vs Cushing's Syndrome: The Features That Separate Them

Why Cushing’s syndrome and PCOS get confused

Cushing’s syndrome is rare — an estimated 0.7 to 2.4 new cases per million people every year — while PCOS affects roughly 1 in 8 women, so the two are nowhere near equally likely. The confusion happens anyway because both conditions disrupt the same hormonal axis from different directions. PCOS raises androgens and, in most phenotypes, insulin; Cushing’s syndrome floods the body with cortisol from a pituitary tumour (Cushing’s disease), an adrenal tumour, or long-term glucocorticoid medication. Both disruptions can stop regular ovulation and both can drive acne, excess facial or body hair, and weight gain — a 2025 review found Cushing’s syndrome is “remarkably prevalent” among young women who present with exactly this cluster, sometimes alongside an existing PCOS diagnosis rather than instead of one.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same mechanism — only the label changed. This article uses PCOS, since that is still the term most readers search.

Cushing’s syndrome sits in the same category of question as PCOS vs endometriosis and high prolactin vs PCOS: a condition that produces enough of the same picture that it has to be actively considered and tested for, not assumed away because a PCOS diagnosis already exists or already seems likely from symptoms alone.

What actually separates them, feature by feature

The two conditions share four symptoms and diverge on almost everything else, especially where fat, skin and muscle changes show up.

Cortisol excess vs PCOS: the exam findings worth weighing most

Four physical signs carry outsized diagnostic value, and none of them are part of the standard PCOS picture. The Endocrine Society’s guideline on diagnosing Cushing’s syndrome recommends testing for it specifically in patients with multiple, progressive features that carry high discriminatory value — and names wide purple striae, easy bruising, proximal muscle weakness, and facial plethora as the features that matter most, because ordinary weight gain, acne and mild hirsutism are common enough on their own to be poor discriminators.

A wide stretch mark is not the same finding as a Cushing’s stretch mark. Ordinary striae from weight change are usually under a centimetre wide and pale or silvery. Cushing’s-associated striae are wider than a centimetre, often purple or red, and can appear on the abdomen, thighs, breasts or upper arms even without a large weight change. Proximal weakness is checked with a simple test: standing up from a low chair without using your hands, or climbing a flight of stairs. PCOS does not weaken muscle; cortisol excess does, because cortisol breaks down muscle protein for fuel.

The facial change deserves its own note, since it is one of the more searched features of this comparison: the rounded “moon face” of Cushing’s syndrome, what actually causes ordinary PCOS facial fullness instead, and the red flags that separate the two are covered in full separately. Facial shape alone is a poor discriminator between the two conditions — the striae, muscle weakness, and bruising below carry far more diagnostic weight.

Where the fat sits matters as much as how much of it there is. PCOS-related abdominal weight gain concentrates centrally but distributes fairly evenly across the trunk and limbs, and it tracks with the insulin resistance several phenotypes carry rather than with cortisol. Cushing’s fat redistribution is more specific: the trunk gains disproportionately while the arms and legs stay thin or even lose muscle mass, producing a silhouette that looks different from ordinary central weight gain even at a similar total weight.

Who actually needs to be screened for Cushing’s

Screening every irregular cycle for Cushing’s syndrome would produce far more false alarms than real diagnoses, given how rare the condition is against how common PCOS-like symptoms are. The 2008 Endocrine Society guideline recommends testing specifically for patients with multiple and progressive Cushingoid features, or an adrenal incidentaloma found on unrelated imaging — not for hyperandrogenism or irregular cycles alone.

Diabetes and blood pressure that resist treatment are a separate reason to look closer. In a 2003 study of 200 overweight patients with poorly controlled type 2 diabetes, a screening dexamethasone test flagged 47 for further work-up, and occult Cushing’s syndrome was confirmed in 4 of them — 2% of the full group — with another 3.5% left with an unresolved mild abnormality on the same axis. That is a meaningfully higher rate than the general population, which is why glucose and blood pressure that will not respond to standard treatment, alongside PCOS-like symptoms, is a reasonable trigger for cortisol testing even without striae or muscle weakness. A 2022 review on differentiating PCOS from adrenal disorders confirms the dexamethasone suppression test is the test routinely used to make this specific call.

The test that tells them apart

For PCOS, the 2023 international guideline specifies androgen levels plus a pelvic ultrasound or AMH level, applied after other causes of the same picture are excluded. For Cushing’s syndrome, the 2008 Endocrine Society guideline recommends starting with one high-accuracy test — 24-hour urinary free cortisol, late-night salivary cortisol, or a 1mg overnight dexamethasone suppression test — before exogenous steroid use has been ruled out, since creams, inhalers, and injections can all produce a Cushingoid picture without a tumour anywhere. An abnormal first test is followed by a second, different test; only concordant abnormal results on two tests move a patient to imaging and a search for the source.

This does not apply to you if…

Cortisol testing has low value if none of the high-discriminatory features are present. Ordinary acne, ordinary hirsutism, and gradual central weight gain without purple striae, muscle weakness, or facial plethora describe the overwhelming majority of PCOS presentations, and testing everyone who fits that description for Cushing’s syndrome would mean chasing a false positive far more often than finding a real one. Cortisol testing earns its place when the picture is progressive, when standard PCOS treatment is not doing what it should for diabetes or blood pressure, or when one of the four discriminating physical signs is actually present.

Your next step

Look for the three signs that PCOS does not explain: stretch marks over a centimetre wide and purple rather than silver, trouble standing from a low chair without your hands, and blood pressure or glucose numbers that resist standard treatment. If any of the three are present, ask your doctor for a cortisol screening test by name — 24-hour urinary free cortisol, late-night salivary cortisol, or a low-dose dexamethasone suppression test — rather than assuming an existing PCOS diagnosis already accounts for everything. See what the full PCOS diagnostic work-up covers, test by test, if you have not been formally diagnosed at all, or start at the diagnosis hub for the rest of the exclusion list the 2023 guideline requires before a PCOS diagnosis is confirmed.